FONTANARI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 217
EU - Europa 159
AS - Asia 62
Totale 438
Nazione #
US - Stati Uniti d'America 217
IT - Italia 52
IE - Irlanda 34
SE - Svezia 32
RU - Federazione Russa 27
HK - Hong Kong 24
CN - Cina 16
JO - Giordania 10
SG - Singapore 7
CH - Svizzera 6
DE - Germania 3
GB - Regno Unito 2
ID - Indonesia 2
FI - Finlandia 1
IN - India 1
IR - Iran 1
KR - Corea 1
RO - Romania 1
UA - Ucraina 1
Totale 438
Città #
Dublin 34
Ashburn 30
Fairfield 26
Moscow 26
Chandler 25
Hong Kong 17
Lawrence 10
Seattle 10
Woodbridge 10
Altamura 9
Cambridge 9
Florence 8
Houston 8
Shanghai 8
Wilmington 7
Bern 6
Buffalo 6
Princeton 6
Singapore 6
Washington 5
Beijing 4
Boston 4
Kent 4
Napoli 4
New York 4
Boardman 3
Luni 3
Ann Arbor 2
Chengdu 2
Medford 2
San Giovanni Valdarno 2
Sant'elpidio A Mare 2
Abenberg 1
Atlanta 1
Bremen 1
Campi Bisenzio 1
Catanzaro 1
Chicago 1
Frankfurt am Main 1
Hangzhou 1
Helsinki 1
Hillsboro 1
Jacksonville 1
Karur 1
Laurel 1
Leawood 1
Milan 1
Monteriggioni 1
Norwalk 1
Prescot 1
Redmond 1
San Diego 1
San Giovanni Lupatoto 1
San Mateo 1
Scarperia e San Piero 1
Seoul 1
Sesto Fiorentino 1
Specchia 1
Totale 328
Nome #
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 97
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab 68
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 53
Increased rates of hand ischemia following arterial cannulation in patients with severe COVID19-related pneumonia 51
Bedside diagnostic laparoscopy for critically ill patients in the Intensive Care Unit: Retrospective study and review of literature 48
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 44
Effectiveness of Tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real life study 35
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 29
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 19
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 14
Totale 458
Categoria #
all - tutte 2.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 4 3
2020/202175 2 2 21 18 3 0 0 10 6 4 9 0
2021/202265 0 15 2 1 4 3 3 2 3 2 13 17
2022/2023161 13 35 9 6 3 35 21 10 20 0 0 9
2023/2024148 0 10 15 6 12 22 8 27 9 16 15 8
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 458